Free Trial

U.S. Physical Therapy (NYSE:USPH) Earns Outperform Rating from Analysts at JMP Securities

U.S. Physical Therapy logo with Medical background

JMP Securities started coverage on shares of U.S. Physical Therapy (NYSE:USPH - Free Report) in a research report sent to investors on Monday morning, Marketbeat.com reports. The brokerage issued an outperform rating and a $113.00 price objective on the stock.

Other research analysts also recently issued reports about the stock. JPMorgan Chase & Co. upped their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Tuesday, December 3rd. Bank of America upgraded U.S. Physical Therapy from a "neutral" rating to a "buy" rating and increased their target price for the company from $100.00 to $115.00 in a research note on Monday. StockNews.com raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Wednesday, August 21st. Finally, Barrington Research reissued an "outperform" rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a report on Thursday, November 21st. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, U.S. Physical Therapy has a consensus rating of "Moderate Buy" and a consensus target price of $114.00.

View Our Latest Analysis on U.S. Physical Therapy

U.S. Physical Therapy Stock Up 2.2 %

NYSE:USPH traded up $2.10 during mid-day trading on Monday, hitting $95.56. The company had a trading volume of 119,458 shares, compared to its average volume of 93,600. The business has a fifty day simple moving average of $89.32 and a 200-day simple moving average of $89.89. The firm has a market capitalization of $1.44 billion, a price-to-earnings ratio of 99.43, a PEG ratio of 4.23 and a beta of 1.46. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy has a 1 year low of $76.18 and a 1 year high of $113.63.

U.S. Physical Therapy Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 15th were issued a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 1.84%. The ex-dividend date was Friday, November 15th. U.S. Physical Therapy's dividend payout ratio (DPR) is 187.23%.

Insider Transactions at U.S. Physical Therapy

In other news, Director Bernard A. Harris, Jr. sold 2,000 shares of the stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total value of $185,900.00. Following the completion of the sale, the director now owns 16,726 shares in the company, valued at $1,554,681.70. This represents a 10.68 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.29, for a total transaction of $166,003.96. Following the completion of the sale, the chief operating officer now directly owns 7,106 shares of the company's stock, valued at $684,236.74. This trade represents a 19.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 7,412 shares of company stock valued at $706,605. Company insiders own 1.70% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Geode Capital Management LLC raised its position in shares of U.S. Physical Therapy by 1.3% during the third quarter. Geode Capital Management LLC now owns 343,073 shares of the company's stock valued at $29,040,000 after buying an additional 4,477 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new stake in U.S. Physical Therapy during the 3rd quarter worth about $573,000. MML Investors Services LLC grew its holdings in U.S. Physical Therapy by 12.7% during the third quarter. MML Investors Services LLC now owns 11,826 shares of the company's stock valued at $1,001,000 after purchasing an additional 1,329 shares during the period. Southernsun Asset Management LLC raised its holdings in U.S. Physical Therapy by 10.5% in the third quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company's stock worth $46,302,000 after purchasing an additional 52,062 shares during the period. Finally, State Street Corp boosted its position in shares of U.S. Physical Therapy by 17.5% during the third quarter. State Street Corp now owns 667,868 shares of the company's stock worth $56,522,000 after purchasing an additional 99,244 shares in the last quarter.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Stories

Should you invest $1,000 in U.S. Physical Therapy right now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines